Product

Dobutamine

12 clinical trials

21 indications

Indication
Sepsis
Indication
Hypoperfusion
Indication
Hyperlactatemia
Indication
Shock
Indication
Cardiogenic
Indication
Cardiomyopathy
Indication
Cardiac surgery
Indication
Dobutamine
Indication
Milrinone
Indication
Pediatrics
Indication
Septic Shock
Clinical trial
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy
Status: Completed, Estimated PCD: 2023-07-24
Clinical trial
Director, Head of Anesthesiology and Critical Care, Principal Investigator, Professor
Status: Not yet recruiting, Estimated PCD: 2027-04-30